Kane Biotech Stock

Kane Biotech P/B

The P/B (Price-to-Book Ratio) of Kane Biotech (KNE.V) as of Aug 7, 2026 is -4.46. In the previous year, P/B (Price-to-Book Ratio) was -0.69 — a change of 548.07% (lower).

P/B

-4.46

YoY

548.07%

Last updated:

P/B (Price-to-Book Ratio) of Kane Biotech is 2026 -4.46 . P/B (Price-to-Book Ratio) of Kane Biotech was 2025 -0.69 . It decreases by 548.07% lower compared to the previous year.
Access this data via the Eulerpool API

Kane Biotech Stock analysis

What does Kane Biotech do? Kane Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kane Biotech stock

P/B (Price-to-Book Ratio) of Kane Biotech is -4.46 in 2026.

P/B (Price-to-Book Ratio) of Kane Biotech changed from -0.69 to -4.46, representing a 548.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Kane Biotech since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Kane Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Kane Biotech

All Key Metrics — Kane Biotech